Vanguard Group Inc Cullinan Oncology, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,998,714 shares of CGEM stock, worth $37.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,998,714
Previous 2,871,375 4.43%
Holding current value
$37.7 Million
Previous $50.1 Million 0.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$16.03 - $20.86 $2.04 Million - $2.66 Million
127,339 Added 4.43%
2,998,714 $50.2 Million
Q2 2024

Aug 13, 2024
BUY
$15.63 - $29.35 $17.1 Million - $32.2 Million
1,097,030 Added 61.83%
2,871,375 $50.1 Million
Q1 2024

May 10, 2024
BUY
$10.17 - $19.02 $29,513 - $55,196
2,902 Added 0.16%
1,774,345 $30.2 Million
Q4 2023

Feb 14, 2024
BUY
$7.89 - $10.23 $654,159 - $848,169
82,910 Added 4.91%
1,771,443 $18.1 Million
Q3 2023

Nov 14, 2023
SELL
$9.05 - $11.72 $3.07 Million - $3.97 Million
-338,873 Reduced 16.71%
1,688,533 $15.3 Million
Q2 2023

Aug 14, 2023
SELL
$8.8 - $13.4 $4.64 Million - $7.07 Million
-527,582 Reduced 20.65%
2,027,406 $21.8 Million
Q1 2023

May 15, 2023
SELL
$10.2 - $11.91 $2.63 Million - $3.07 Million
-257,977 Reduced 9.17%
2,554,988 $26.1 Million
Q4 2022

Feb 10, 2023
BUY
$9.72 - $13.62 $466,171 - $653,215
47,960 Added 1.73%
2,812,965 $29.7 Million
Q3 2022

Nov 14, 2022
BUY
$11.82 - $15.42 $230,324 - $300,474
19,486 Added 0.71%
2,765,005 $35.4 Million
Q2 2022

Aug 12, 2022
BUY
$7.31 - $13.55 $2.88 Million - $5.33 Million
393,394 Added 16.73%
2,745,519 $35.2 Million
Q1 2022

May 13, 2022
SELL
$10.47 - $16.75 $153,731 - $245,940
-14,683 Reduced 0.62%
2,352,125 $24.6 Million
Q4 2021

Feb 14, 2022
BUY
$15.36 - $25.0 $1.31 Million - $2.13 Million
85,357 Added 3.74%
2,366,808 $36.5 Million
Q3 2021

Nov 12, 2021
BUY
$22.56 - $29.68 $25.4 Million - $33.4 Million
1,125,686 Added 97.4%
2,281,451 $51.5 Million
Q2 2021

Aug 13, 2021
BUY
$24.96 - $41.25 $28.8 Million - $47.7 Million
1,155,765 New
1,155,765 $29.8 Million

Others Institutions Holding CGEM

# of Institutions
146
Shares Held
67.6M
Call Options Held
612K
Put Options Held
118K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $574M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email